QTTB Q1 2021 Earnings — Q32 Bio Inc. Revenue & Financial Results | Market Cap Arena

QTTBQ32 Bio Inc.

$83M

Q1 2021 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$29M+4883.8% YoY

Gross Profit

$00.0% margin

Operating Income

-$1M-3.8% margin

Net Income

-$1M-3.7% margin

EPS (Diluted)

$-0.38

QoQ Revenue Growth

+2890.3%

Cash Flow

Operating Cash Flow

-$30M

Free Cash Flow

-$31M

Stock-Based Comp.

$0

Balance Sheet

Total Assets

$235M

Total Liabilities

$34M

Stockholders' Equity

$201M

Cash & Equivalents

$104M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$29M	$588,000	+4883.8%
Gross Profit	$0	$0	—
Operating Income	-$1M	-$36M	+97.0%
Net Income	-$1M	-$35M	+97.0%